Venable has a long record of achieving outstanding results in complex patent disputes. Our attorneys have successfully represented patent holders and defended accused infringers in federal courts, arbitration, and mediation across the country, and before the International Trade Commission (ITC).
Our clients include Fortune 500 companies, emerging companies, and industrial and consumer product manufacturers. We have handled matters involving such technologies as visual voicemail, software systems, vaccines, high-frequency digital battery chargers, flashlights, satellite components, targeted cancer therapies, and cryogenic surgical devices.
We work closely with clients to devise the most effective strategy for each case. We are committed to providing our clients with exceptional client service and added value.
Venable's Patent Litigation team is led by seasoned trial lawyers with significant experience handling complex, high-profile patent matters. They are supported by Venable's Patent Prosecution Group, which boasts dozens of attorneys with advanced degrees in chemistry, biotechnology, immunology, physics, computer science, and electrical and mechanical engineering. We also call upon our skilled colleagues in Venable's Government and Regulatory Affairs practices when issues involving FDA regulations, antitrust, tax, and government contracts, among others, arise.
Experience in Key Venues
Venable’s patent litigators have a proven track record in key "rocket-docket" venues in the Eastern District of Texas and the Eastern District of Virginia, and in federal court in Delaware, an increasingly popular patent venue. We have tried major patent cases before the International Trade Commission, and have extensive experience handling interferences, reexaminations and other post-grant proceedings before the U.S. Patent and Trademark Office. Venable’s litigators have also recorded wins in precedential appeals before the Federal Circuit and filed numerous amicus briefs in notable patent appeals.
Client Focus
- Biotechnology
- Chemistry
- Consumer products
- Financial institutions
- Manufacturing processes
- Medical devices
- Microprocessors
- Pharmaceuticals
- Research institutions
- Satellites
- Software
- Sporting goods
- Telecommunications